A A

Tomorrow's health, today

 

PUBLISHED ON 

SCROLL DOWN

Research is what enables National University Health System (NUHS) to stay at the forefront of developing precision tools in treatments and predictive markers for early detection.

By adopting a personalised approach, clinicians can tailor treatments to each individual, maximising effectiveness and minimising potential side effects.

Shaping tomorrow’s health through clinical research and innovation

With the goal of advancing health in Singapore, NUHS as an Academic Health System, spearheads innovation and research projects that can augment its ability to deliver better care. NUHS conducts clinical trials to explore the safety and efficacy of novel treatments, drugs, and medical devices. These trials enhance the understanding of specific diseases and provide valuable insights into potential treatments and prevention methods.

Predictive medicine is rooted in proactive and preventative care

Being able to anticipate future illnesses and predict the course of a future disease allows for early detection and life-changing treatment.

Precision medicine takes into account the prevention, diagnosis and treatment of diseases

This includes more precise technologies which can pinpoint genes associated with specific diseases. It also applies to how an individual's genomic, environmental and lifestyle information can guide decisions related to their treatment.

Personalised medicine is defined by individualised treatment

The use of precision tools and predictive markers allow clinicians to characterise their patients and develop an individualised approach. This can determine the correct treatment course or dosage to optimise success and minimise side-effects.

What if we could transform the future of science and medicine?

Today, we are turning standardised care into personalised care, precision is redefining our protocols, and what was once curable is becoming predictable.

The NUHS Scientific and Innovation Summit 2024 highlighted Singapore's cutting-edge scientific and clinical research capabilities, fostering knowledge exchange and best practices in medical science. The signature event gathered over 500 international and local healthcare experts, opinion leaders and scientists to shape the future of healthcare together.

Keep reading to discover more about the future of healthcare in Singapore and delve into NUHS’s groundbreaking research and innovation efforts.

Dr Gao Yujia

Aside from his pioneering work at the National University Hospital (NUH) HoloMedicine programme, Dr Gao has a special interest in using AI to improve surgical excellence.

Read more.

Dr Anand Jeyasekharan

Working across the National University Cancer Institute (NCIS) and NUS, Dr Anand uses AI and spatial biology to better understand cancer. In-depth analysis of cancer using advanced imaging equipment has enabled him and his team to develop more precise treatment options.

Read more.

Dr Jocelyn Chew

Dr Chew is developing an app that incorporates AI. Her goal is to identify and tackle patients’ dietary triggers along with personalised prompts and alerts to help with weight management.

Read more.

A/Prof Kavita Venkataraman

A clinician and epidemiologist, A/Prof Kavita is interested in researching cardiometabolic diseases. She is currently focused on peripheral arterial disease as a complication related to diabetes.

Read more.

Dr Daniel Huang

As a gastroenterologist at NUH, Dr Huang looks after patients with advanced liver diseases. He is working to predict detect and treat Hepatocellular carcinoma (HCC), one of the world’s most lethal cancers.

Read more.

A/Prof Su Xinyi

As a clinician-scientist, A/Prof Su’s research interests are in developing biomaterials and translational stem cell therapeutics for retinal diseases.

Read more.

A/Prof Helen Zhou

As head of the neuroimaging lab at NUS Centre for Sleep and Cognition, A/Prof Helen’s research focuses on neurodegenerative disorders. She is studying how precision medicine can screen for early signs of dementia and slow down cognitive decline.

Read more.

A/Prof Choi Hyung Won

By looking into cardiac biomarkers such as protein and lipid levels in patients who have had heart attacks, A/Prof Choi hopes to find new ways to predictively profile patients with heart injury symptoms. Still in its early stages, his research aims to create a predictive heart disease blood marker test that would enable screening at a population level.

Read more.

NUHS Scientific and Innovation Summit 2024

NUHS Scientific and Innovation Summit is organised by NUHS, to provide a platform to showcase Singapore’s scientific and clinical research capabilities, and facilitate the sharing of knowledge and best practices in medical science.

Click to view event photos and video.